Skip to content
Peptigraph home

Peptides for Sleep

The peptides people most often research for sleep, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Peptides listed
8
With human trials
4
FDA approved (any use)
2
Showing 8 peptides · ordered by search interest for this goal
  1. DSIPSleep peptideHuman RCT evidence, 4 of 4European journal of anaesthesiology 2009, PMID 19142086Human76Animal306Summarised9PCAC did not recommend (Jul 2026)For sleepOverview
  2. SermorelinGHRH analogNo study with an outcome for sleepPubMed search, 11 Oct 2026Human2Animal0Summarised0Compounded by prescriptionFor sleepOverview
  3. CJC-1295GHRH analogHuman observational evidence, 3 of 4Substance use & misuse 2016, PMID 26771670Human2Animal0Summarised1Not FDA approved · research chemicalFor sleepOverview
  4. HGHRecombinant growth hormoneHuman RCT evidence, 4 of 4European journal of endocrinology 2013, PMID 23447518Human153Animal6Summarised3FDA approved (prescription only)For sleepOverview
  5. TesamorelinGHRH analogHuman RCT evidence, 4 of 4eNeurologicalSci 2026, PMID 42382101Human1Animal0Summarised1FDA approved (Egrifta)For sleepOverview
  6. SelankTuftsin analogNo study with an outcome for sleepPubMed search, 11 Oct 2026Human3Animal0Summarised0Not FDA approved · research chemicalFor sleepOverview
  7. BPC-157Gastric pentadecapeptideNo study with an outcome for sleepPubMed search, 11 Oct 2026Human1Animal0Summarised0PCAC voted 8–6 for 503A (Jul 2026)Overview
  8. IpamorelinGHRP (ghrelin receptor agonist)No study with an outcome for sleepPubMed search, 11 Oct 2026Human1Animal0Summarised0Not FDA approved · research chemicalOverview
Read this first

What this list does not show

Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.

Search interest is not evidence

This list follows what people search for and discuss. It says nothing about how well any peptide works.

Animal results may not carry over

Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.

Approval covers specific uses

An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.

Combinations are a separate question

Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.

What sleep disorders are

MedlinePlus defines sleep disorders as conditions that disturb normal sleep patterns, and names insomnia, trouble falling or staying asleep, as one general type.[25]

It stresses that quality of sleep matters as well as hours, and that poor-quality sleep can affect physical and mental health, thinking and daily functioning.[25]

DSIP is the only peptide with sleep trials, and they are old

PubMed records matching the site's sleep search (many peptides here only match incidentally): DSIP 76 human-only and 306 animal-only; Sermorelin 2 human-only and 0 animal-only; CJC-1295 2 human-only and 0 animal-only; growth hormone 153 human-only and 6 animal-only; Tesamorelin 1 human-only and 0 animal-only; Selank 3 human-only and 0 animal-only; BPC-157 1 human-only and 0 animal-only; Ipamorelin 1 human-only and 0 animal-only.

Calculated from goal sleep; ledger date 2026-10-02; counts dsip (human only 76, animal 306, rct 5), sermorelin (human only 2, animal 0, rct 1), cjc-1295 (human only 2, animal 0, rct 0), hgh (human only 153, animal 6, rct 14), tesamorelin (human only 1, animal 0, rct 0), selank (human only 3, animal 0, rct 1), bpc-157 (human only 1, animal 0, rct 0), ipamorelin (human only 1, animal 0, rct 0). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).

In a placebo-controlled polysomnography trial in chronic insomniacs, DSIP gave higher sleep efficiency and shorter sleep latency than placebo.[26]

The same trial's authors concluded that short-term treatment of chronic insomnia with DSIP is not likely to be of major therapeutic benefit because subjective sleep quality did not change.[26]

An earlier controlled trial judged sleep improvement under DSIP to be of little clinical significance.[27]

An anaesthesia trial found the opposite of the hypnotic effect expected: DSIP reduced delta rhythm and raised the depth-of-anaesthesia index (BIS).[1]

Growth hormone and tesamorelin on sleep

Growth hormone replacement did not affect night sleep or daytime sleep propensity in GH-deficient adults in one trial.[28]

A low-dose tesamorelin trial found no significant change in body composition, fatigue, sleep, physical performance, glucose tolerance or cognition.[4]

Common questions

What is the best peptide for sleep?

DSIP is the only one with sleep trials, and its authors concluded that the benefit in chronic insomnia is not likely to be major.[26]

Does DSIP work for insomnia?

Results are mixed across small trials: one found sleep improvement of little clinical significance, another reported substantially improved night sleep.[29]

Is there recent human evidence for DSIP and sleep?

The cached human trials are decades old and small, and the animal data include a DSIP fusion peptide that may enhance sleep in insomniac mice.[30]

Does CJC-1295 improve sleep?

The only human CJC-1295 record on sleep is a forum study in which users cited improved sleep as a reason for use, which reports motives and not measured results.[2]

Sources

  1. 1Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.European journal of anaesthesiology · 2009PMID 19142086Accessed 2 Oct 2026
  2. 2Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Substance use & misuse · 2016PMID 26771670Accessed 2 Oct 2026
  3. 3Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin.European journal of endocrinology · 2013PMID 23447518Accessed 2 Oct 2026
  4. 4The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci · 2026PMID 42382101Accessed 2 Oct 2026
  5. 5PubMed search: (sermorelin[tiab] OR Geref[tiab]) (34 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: (sermorelin[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab] OR "GHRH 1-29"[tiab]) AND (elderly[tiab] OR aging[tiab] OR "older adults"[tiab] OR adults[tiab]) AND (treatment[tiab] OR therapy[tiab] OR administration[tiab]) (15 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: (sermorelin[tiab] OR Geref[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: selank[tiab] (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: selank[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: (selank[tiab] OR semax[tiab]) AND (randomized[tiab] OR patients[tiab] OR clinical[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: "BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab] (230 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: "BPC-157"[tiab] AND humans[mh] (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (patients[tiab] OR clinical trial[pt] OR randomized[tiab]) (25 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (colitis[tiab] OR inflammatory bowel[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (tendon[tiab] OR ligament[tiab] OR muscle[tiab] OR bone[tiab] OR arthritis[tiab]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  17. 17PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (nerve[tiab] OR neuropath*[tiab] OR spinal[tiab] OR liver[tiab] OR wound[tiab] OR burn[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  18. 18PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  19. 19PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  20. 20PubMed search: (sermorelin[tiab] OR Geref[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  21. 21PubMed search: selank[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  22. 22PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (57 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  23. 23PubMed search: ("BPC-157"[tiab] OR "BPC 157"[tiab]) AND (human[tiab] OR patient*[tiab] OR volunteer*[tiab]) AND (adverse[tiab] OR safety[tiab] OR "side effects"[tiab]) (19 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  24. 24PubMed search: ipamorelin[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  25. 25Official web pageOfficial web page · web page
  26. 26Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.Neuropsychobiology · 1992PMID 1299794Accessed 2 Oct 2026
  27. 27Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.International journal of clinical pharmacology research · 1987PMID 3583493Accessed 2 Oct 2026
  28. 28Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.Psychoneuroendocrinology · 2005PMID 15358440Accessed 2 Oct 2026
  29. 29Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.European neurology · 1987PMID 3622582Accessed 2 Oct 2026
  30. 30Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models.Frontiers in pharmacology · 2024PMID 39444618Accessed 2 Oct 2026

Found an error? Report a correction.